Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations
Masamichi Fukuda, Shinsuke Shibata, Naoko Shibata, Kenta Hagihara, Hiromoto Yaguchi, Hiromi Osada, Nobuo Takahashi, Eri Kubo, Hiroshi SasakiDepartment of Ophthalmology, Kanazawa Medical University, Uchinada, JapanPurpose: To investigate the safety of five types of antiglaucoma prostaglandin analog o...
Main Authors: | Fukuda M, Shibata S, Shibata N, Hagihara K, Yaguchi H, Osada H, Takahashi N, Kubo E, Sasaki H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-03-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/safety-comparison-of-additives-in-antiglaucoma-prostaglandin-pg-analog-a12450 |
Similar Items
-
Effects of prostaglandin analogs on blood flow velocity and resistance in the ophthalmic artery of rabbits
by: Amália Turner Giannico, et al.
Published: (2016-02-01) -
Corneal epithelial toxicity of antiglaucoma formulations: in vitro study of repeated applications
by: Meloni M, et al.
Published: (2012-09-01) -
Forskolin: Upcoming antiglaucoma molecule
by: V D Wagh, et al.
Published: (2012-01-01) -
Conjunctiva-associated lymphoid tissue (CALT) reactions to antiglaucoma prostaglandins with or without BAK-preservative in rabbit acute toxicity study.
by: Hong Liang, et al.
Published: (2012-01-01) -
Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs
by: Constantin Tănase, et al.
Published: (2021-02-01)